newsfilter
← Latest News
GlobeNewswire·

Constellation Pharmaceuticals Announces First-Quarter 2021 Financial Results and Provides Business Update

Dosing underway in the Phase 3 MANIFEST-2 clinical trial Recommended Phase 2 dose determined for CPI-0209 and first patient dosed in the Phase 2 expansion cohorts Upcoming data presentation at ASCO supports the best-in-class target engagement potentia